More cancer patients live longer. Few get the help they need to stay healthy. 50-year Hodgkin Lymphoma survivor, Susan Leigh, describes the challenges of long-term cancer survivors.
A wonderful history of the “War on Cancer” and includes several quotes from Dr. Vincent DeVita–one of our Hodgkin lymphoma heroes! Also mentioned in the article is our “own” Susie Leigh, fellow long-term Hodgkin lymphoma survivor.
In this issue of the Journal, de Vries and colleagues examine the cause-specific late mortality among a multi-center Dutch cohort of Hodgkin lymphoma survivors.
Radiation therapy plays a critical role in treating head and neck cancers, but it can also lead to lasting late effects that impact quality of life long after treatment ends. One of the most common of these is Radiation Fibrosis Syndrome (RFS) — a chronic condition caused by radiation-induced damage to soft tissues, nerves, and lymphatic structures.
Cancer-related fatigue plagues many long-term survivors. This article provides practical strategies to help manage persistent fatigue. For Hodgkin lymphoma survivors, addressing fatigue is often central to improving quality of life, as it is a common long-term effect of treatment and chronic stress on the body.
Initiating annual breast cancer screening at a younger age may prevent more than half of all breast cancer-related deaths among childhood cancer survivors treated with chest radiation, according to results of a comparative modeling study presented at this year’s ASCO Annual Meeting.
The good news is that for most patients, the long-term prognosis for childhood Hodgkin lymphoma is excellent. For patients who have been through months or even years of difficult chemotherapy and radiation therapy, it is easy to see the final treatment—the declaration of “cancer free” or even “cured”—as the final destination of a long journey. Survivorship, however, is in fact its own journey, and one that can also be extremely challenging, both physically and emotionally.
Survivors of childhood Hodgkin lymphoma are at an increased risk of developing an entirely new cancer later in life, according to new research published in Cancer—the American Cancer Society’s international peer-reviewed scientific journal—and conducted at University of Alabama at Birmingham.